Clinical Trials Logo

Arrhythmia clinical trials

View clinical trials related to Arrhythmia.

Filter by:

NCT ID: NCT05967546 Not yet recruiting - Arrhythmia Clinical Trials

Deep Learning for Intelligent Identification of Arrhythmias

ECG-LEARNING
Start date: December 30, 2024
Phase:
Study type: Observational

This study aims to design and train a deep learning model for the diagnosis of different arrhythmias.

NCT ID: NCT05961865 Recruiting - Atrial Fibrillation Clinical Trials

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

POLICARDIOFA
Start date: July 11, 2023
Phase:
Study type: Observational

It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity, clinical risk factors and their possible variation following an AF ablation procedure

NCT ID: NCT05957315 Not yet recruiting - Arrhythmia Clinical Trials

Mobile Cardiac Outpatient Telemetry for Unexplained Syncope

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This study seeks to provide evidence that use of Philips mobile cardiac outpatient telemetry (MCOT) devices may improve patient care for patients who present to emergency departments (EDs) with syncope, which is a temporary loss of consciousness also known as fainting or who present experiencing a near temporary loss of consciousness (near syncope). It is set up as a random controlled trial, which means research participants will be randomly assigned to receiving the device or usual care. Patients 50 years or older who come to the ED of Carilion Roanoke Memorial Hospital will be screened by study team members for unexplained syncope or near syncope across three ED dispositions: hospital admission, emergency department clinical decision unit admission (ED CDU) and emergency department. After consent, subjects will be enrolled and randomized, via REDCap randomization, in the study. At the time of subject discharge the MCOT device will be placed on the chest for the arm of intervention patients (for subjects who were admitted, the research study team will follow the patient's clinical course and placement of the device will occur at discharge); subjects will also receive brief instruction on the care and maintenance of the device and a patient education guide. The research team will contact the subjects for a telephone follow up at 14 and 30 days post-enrollment. The study will establish the efficacy of mobile cardiac outpatient telemetry in comparison to observation telemetry. Research objectives are to 1) Measure the time to medical intervention in patients with unexplained syncope or near syncope fitted with a Philips MCOT at the time of hospital discharge compared to patients treated with usual care for unexplained syncope or near syncope; and 2) Measure the time to arrhythmia diagnosis in patients with unexplained syncope or near syncope fitted with a Philips MCOT at the time of hospital discharge compared to patients treated with usual care for unexplained syncope or near syncope.

NCT ID: NCT05883631 Recruiting - Atrial Fibrillation Clinical Trials

RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

RESOLVE-AF
Start date: October 23, 2023
Phase: N/A
Study type: Interventional

Demonstrate the safety and effectiveness of the Ablacathâ„¢ Mapping Catheter and Ablamap® System in patients with all types of atrial fibrillation (AF) including paroxysmal or persistent or long-standing persistent, undergoing and De Novo or Redo procedures. Phenotype patients and demonstrate the prognostication power of Electrographic Flow (EGF®) maps among all subjects using 12-month follow-up outcomes following EGF-guided mapping and ablation.

NCT ID: NCT05694273 Not yet recruiting - Arrhythmia Clinical Trials

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

CENTRAL
Start date: January 15, 2025
Phase:
Study type: Observational

This study aims to evaluate the incidence, clinical characteristics, and short-term prognosis of acute cerebrovascular events occurring in-hospital in patients with arrhythmias following catheter ablation. The goal is to provide evidence supporting the improvement of patient quality of life and reduction of in-hospital acute cerebrovascular complications in patients with post-ablation arrhythmias. This will also contribute to the evidence-based clinical management of such patients.

NCT ID: NCT05640323 Completed - Healthy Clinical Trials

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Pulse Rate

Start date: April 26, 2023
Phase:
Study type: Observational

The study will evaluate the mean average error (MAE) of measuring pulse rate using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

NCT ID: NCT05636046 Recruiting - Cardiac Disease Clinical Trials

Transseptal Italian Registry (TITLE)

TITLE
Start date: November 20, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about the changing over the time of transseptal (TSP) catheterization for catheter ablation of arrhythmias in the left heart. This study aims to investigate if auxiliary tools for TSP catheterization improved the safety and efficacy.

NCT ID: NCT05617001 Recruiting - Arrhythmia Clinical Trials

Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)

Start date: October 4, 2022
Phase: N/A
Study type: Interventional

AliveCor (www.alivecor.com) has developed an ECG device (KardiaMobile) that interfaces with iOS and Android smartphones and tablets. This ECG consists of a lightweight hardware case with two metal electrodes that can snap onto the back of the phone and a software application. By holding the right finger(s) on the right electrode and the left finger(s) on the left electrode, an electrical circuit is completed and a lead-I, 30 second rhythm strip is created. KardiaMobile and a newer device, KardiaMobile 6L, were approved by FDA for ECG rhythm recording. Recently, AliveCor developed a new device: Kardia 12L to record 12-lead ECGs. However, the data generated from the new device has not yet been validated for accuracy. The specific aim of this study is to evaluate the accuracy and safety of the AC 12L ECG System. The ECGs collected by the AC 12L ECG System will be compared to simultaneous standard- of-care 12-lead ECG, recorded using the GE CardioSoft 12-lead ECG System. The ECGs will be analyzed for accuracy based on statistical difference using root-mean-square error, and cross correlation between the simultaneous 10 second recordings as well as the median beats of all 12 leads.

NCT ID: NCT05509517 Completed - Atrial Fibrillation Clinical Trials

A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery

SURGICAL-AF 2
Start date: November 2, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the clinical consequences following the detection of postoperative atrial fibrillation or flutter (POAF) using a remote heart rhythm monitoring strategy with a photoplethysmography based smartphone technology in the early postoperative period after discharge.

NCT ID: NCT05486377 Completed - General Anesthesia Clinical Trials

Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia

Start date: August 2, 2022
Phase: Phase 4
Study type: Interventional

In anesthesia for ablation for cardiac arrhythmias, abrupt hemodynamic changes or fatal arrhythmias can be seen frequently. Remimazolam is a novel ultra-short acting benzodiazepine that provides good hemodynamic stability compared to conventional anesthetic agents. This study aims to investigate whether remimazolam reduces vasoactive agent use during cryo/radiofrequancy ablation under general anesthesia, compared to desflurane(RCT).